Загрузка...
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease worldwide. Despite its high prevalence and rising incidence, there are currently no specific targeted pharmacotherapies approved by the Food and Drug Administration (FDA) for nonalcoholic steatohepatitis (NASH). Cur...
Сохранить в:
| Опубликовано в: : | J Clin Exp Hepatol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6926203/ https://ncbi.nlm.nih.gov/pubmed/31889754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.06.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|